Latest News for: anti obesity drug

Edit

Trillion-euro dream fades for slimmed-down Novo Nordisk

The Irish Times 30 Mar 2025
Much of the damage was done in December when the stock tanked after CagriSema, Novo’s experimental anti-obesity drug, achieved a 22.7 per cent weight ...
Edit

Former Citi CEO Sandy Weill Donates $50M to Unite Cancer Researchers

New York Observer 28 Mar 2025
Sign Up ... The hub will additionally evaluate whether emerging therapeutics such as GLP-1 agonists, a class of diabetes and anti-obesity drugs that includes Ozempic and Wegovy, have beneficial effects on the immune cells of cancer patients ... .
Edit

'Ozempic-like' weight loss drug Mounjaro creates buzz amid India launch: Price per month, availability, pros ...

Hindustan Times 26 Mar 2025
In case you missed it, Eli Lilly has launched the anti-obesity drug Mounjaro in India ... with its superior weight loss efficacy positioning it as a strong contender in the growing anti-obesity market.
Edit

SAP leapfrogs Novo Nordisk to become Europe’s most valuable company

The Irish Times 24 Mar 2025
Novo Nordisk has lost half its market value since last summer as it struggles to convince investors that it has a big follow-up to its blockbuster GLP-1 anti-obesity drugs. READ MORE ... .
Edit

Slimmed down Roxy Jacenko continues health kick as she grabs green juice with friends in ...

The Daily Mail 24 Mar 2025
It doesn't even compare to how bad I felt when I took this drug,' she told The Saturday Telegraph ... It is also sold under the brand name Wegovy as an anti-obesity medication for long-term weight management.
Edit

Weight-loss medicine goes on sale in India

Hindustan Times 21 Mar 2025
Dr Nikhil Tandon, head of endocrinology at All India Institute of Medical Sciences (AIIMS) in Delhi, warned against unsupervised use of emerging anti-obesity drugs ... The drug represents a significant ...
Edit

Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects

The Times of India 21 Mar 2025
The pharma manufacturer said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
Edit

India gets first weight-loss drug as Eli Lilly launches Mounjaro

Gulf News 20 Mar 2025
Mounjaro’s launch will give Eli Lilly the first-mover advantage in the country where the unmet demand was so high that users were resorting to procuring anti-obesity drugs from the gray market.
Edit

Obesity and diabetes management drug launched in India by American pharma company Eli Lilly

The Hindu 20 Mar 2025
The market for anti-obesity drugs in India has seen exponential growth, swelling from ₹137 crore in November 2020 to ₹535 crore in November 2024 ....
Edit

Protagonist Therapeutics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025

ACCESSWIRE 18 Mar 2025
An anti-obesity program aimed at providing oral drugs in a market currently dominated by injectables ... The Company also has a number of pre-clinical stage oral drug discovery programs addressing ...
Edit

Anti-Obesity Drugs Market Industry Trends, Sales Forecast, Key Players And Global Forecasts To 2035: Semaglutide ...

MENA FN 17 Mar 2025
(MENAFN - GlobeNewsWire - Nasdaq) The global anti-obesity drugs market is projected to grow from $12.8 billion in 2024 to $104.9 billion by 2035, at a CAGR of 21.1%. The market is driven by GLP-1 ... .
Edit

Oz’s ties to insurers may loom over his CMS confirmation hearing

Roll Call 13 Mar 2025
Oz has praised anti-obesity drugs such as Ozempic, promoting them on his show and his social media channels over the years, while Kennedy has been a critic of the weight loss drugs, and in recent ...
Edit

The truth about blinkered single-issue campaigners

The Spectator 12 Mar 2025
climate change activists lobbying against nuclear energy, anti-smoking campaigners campaigning against e-cigarettes, anti-obesity campaigners complaining about weight loss drugs ... The anti-industry ...
×